Disease-modifying drugs for progressive rheumatoid arthritis
- PMID: 6766523
Disease-modifying drugs for progressive rheumatoid arthritis
Abstract
In patients with rheumatoid arthritis who do not respond to therapy with salicylates or nonsteroidal anti-inflammatory agents, stronger and potentially more toxic drugs are then considered. At the present time in the United States, this generally means a trial of hydroxychloroquine, gold, penicillamine, azathioprine, or cyclophosphamide. Each of these drugs is discussed with regard to pharmacology and possible modes of action, pertinent clinical studies, and toxicity.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical